Summary
Updated Aug 31, 2026
Jarrett Disbrow is Chief Business Officer of AYTU BIOPHARMA, INC (AYTU). 3 SEC Form 4 filings on record going back to 2024, most recently on 30 July 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Jarrett Disbrow has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Jarrett Disbrow's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jarrett Disbrow?
Jarrett Disbrow is a corporate insider, tracked as Chief Business Officer of AYTU BIOPHARMA, INC (AYTU). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jarrett Disbrow submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Jarrett Disbrow's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jarrett Disbrow and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
